← Eichor
Study identifier: NCT06803589 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Growth Hormone for the Treatment of Gastroparesis

Condition: Gastroparesis  ·  Sponsor: Mayo Clinic

PhaseEARLY_Phase 1
Planned participants10
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

This description comes directly from the study's public registry record.

Talk to the study team

Guillermo GI Program Coordinator, Research  ·  480-301-4679  ·  barahona.guillermo@mayo.edu

Tisha Lunsford, MD  ·  lunsford.tisha@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Mayo ClinicPhoenix, Arizona, United StatesRecruiting
Mayo Clinic in ArizonaScottsdale, Arizona, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06803589